NCT07520279
Xpert® Tropical Fever Test on GeneXpert® Edge X System
Enrolling by Invitation
Not specifiedAges 14+ObservationalCepheid
~2,500 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:Xpert Tropical Fever test
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical performance [PPA and NPA] of Xpert Tropical Fever
Measured over Clinical performance on specimens collected at Baseline (Day 0)
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Presents with AFI as defined for endemic populations or fever as defined in non-endemic populations or presents with fever as defined for nonendemic populations
Clinical suspicion of disease caused by at least one of the following: Plasmodium spp, dengue virus, Zika virus, chikungunya virus, or Leptospira (endemic population)
History of residence in or travel to an endemic geographic region within 3 months prior to specimen collection (endemic population)
Exclusion
Self-reported or known antibiotic or antimalarial use (oral or intravenous) within 3 days prior to enrollment (endemic and nonendemic population)
History of residence in or trael to endemic geographic region as defined by protocol ≤ three months prior to specimen collection (nonendemic population)
Clinical suspicion of infection caused by any of the following: Plasmodium spp., dengue virus, Zika virus, chikungunya virus, or Leptospira spp. (nonendemic population)
What this trial measures
- Clinical performance [PPA and NPA] of Xpert Tropical FeverClinical performance on specimens collected at Baseline (Day 0)
Evaluating the PPA and NPA of Xpert Tropical Fever relative to the comparator(s)